Trial intelligence / Profile preview

PLATINUM Trial: Lazertinib Consolidation in Unresectable Stage III EGFR-mutant NSCLC after Chemoradiation

KCT0007226Phase 2Recruiting

Sponsor

Yuhan

Start

Jun 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1